Results 161 to 170 of about 159,323 (346)

Investigating transthyretin variants H88R and I107V in amyloid priming: From destabilization to complete dissociation

open access: yesThe FEBS Journal, EarlyView.
Investigated mutations in transthyretin (TTR) disrupt the F87‐centered hydrophobic core that stabilizes its tetrameric structure. The mild I107V mutation weakens inter‐chain packing, while H88R fully abolishes tetramer formation, yielding a monomeric, aggregation‐prone form. Structural, biophysical, and computational analyses reveal that both mutations
István L. Bódy   +7 more
wiley   +1 more source

Performing Large‐Scale Genetic Analysis in the Bleeding Disorders Community

open access: yesHaemophilia, EarlyView.
ABSTRACT Inherited bleeding disorders encompass a diverse group of conditions caused by genetic defects affecting coagulation factors, fibrinogen, von Willebrand factor, or platelet function. Despite major advances in quantitative and functional laboratory assays, a substantial diagnostic gap remains, particularly in patients with mild or atypical ...
Anna R. Blankstein   +6 more
wiley   +1 more source

Improvement of severe diarrhea by dimethylsulfoxide in a case of AA type secondary amyloidosis.

open access: bronze, 1989
Yoko Okuma   +5 more
openalex   +2 more sources

Assessment of Cardiac Amyloidosis with 99mTc-Pyrophosphate (PYP) Quantitative SPECT [PDF]

open access: green, 2020
Chao Ren   +10 more
openalex   +1 more source

Detection of vascular amyloid deposits in a bone marrow aspirate

open access: yes
British Journal of Haematology, EarlyView.
Konstantinos Liapis   +3 more
wiley   +1 more source

The Underscreening of Cardiac Amyloidosis in Patients With Pacemakers—A Single Centre Retrospective Audit

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Cardiac amyloidosis is commonly associated with cardiac conduction disease. We sought to determine the prevalence of advanced conduction disease requiring a pacemaker in patients with known cardiac amyloidosis to evaluate current screening practices among patients receiving pacemakers.
Peishan Cai   +4 more
wiley   +1 more source

Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis

open access: yesHaematologica, 2018
Richa Manwani   +13 more
doaj   +1 more source

Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans

open access: yesBlood Cancer Journal, 2022
Andrew Staron   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy